GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
November 07 2017 - 9:30PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, today
announced that President and Chief Executive Officer, Hany
Massarany, will present at the Canaccord Genuity Medical
Technologies & Diagnostics Forum in New York, NY.
Mr. Massarany will participate in an analyst-led fireside chat
on Thursday, November 9, at 3:00 PM Eastern Time. Interested
parties may access a live and archived webcast of the event at
ir.genmarkdx.com.
About GenMark Diagnostics
GenMark Diagnostics (NASDAQ:GNMK) is a leading provider of
multiplex molecular diagnostic solutions designed to enhance
patient care, improve key quality metrics, and reduce the total
cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® and ePlex® systems are designed
to support a broad range of molecular diagnostic tests with
compact, easy-to-use workstations and self-contained, disposable
test cartridges. GenMark’s ePlex: The True Sample-to-Answer
Solution™ is designed to optimize laboratory efficiency and address
a broad range of infectious disease testing needs, including
respiratory, bloodstream, and gastrointestinal infections. For more
information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171107006919/en/
Investor Relations ContactGenMark Diagnostics, Inc.Lynn
Pieper Lewis or Leigh Salvo(415)
937-5404investors@genmarkdx.com
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Aug 2024 to Sep 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Sep 2023 to Sep 2024